Stockscreener 앱 받기
125.08
0.99%
1.236
전일 마감가:
$123.84
열려 있는:
$124.295
하루 거래량:
2.27M
Relative Volume:
0.40
시가총액:
$217.71B
수익:
$43.84B
순이익/손실:
$13.90B
주가수익비율:
15.69
EPS:
7.9725
순현금흐름:
$6.92B
1주 성능:
-1.22%
1개월 성능:
-7.07%
6개월 성능:
-5.83%
1년 성능:
+6.31%
1일 변동 폭
$123.84
$125.85
1주일 범위
$122.44
$126.55
52주 변동 폭
$110.86
$140.84
애보트 래버러토리스 Stock (ABT) Company Profile
명칭
Abbott Laboratories
전화
(224) 667-6100
주소
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
ABT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
125.08 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.41 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
360.29 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
89.93 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.88 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
애보트 래버러토리스 Stock (ABT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-10 | 개시 | The Benchmark Company | Buy |
| 2025-07-18 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-06-16 | 개시 | Leerink Partners | Market Perform |
| 2024-10-08 | 개시 | Oppenheimer | Outperform |
| 2024-09-19 | 개시 | Piper Sandler | Overweight |
| 2024-07-30 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-21 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | 재확인 | Barclays | Overweight |
| 2023-04-20 | 재확인 | Bernstein | Outperform |
| 2023-04-20 | 재확인 | JP Morgan | Overweight |
| 2023-04-20 | 재확인 | Raymond James | Outperform |
| 2023-04-20 | 재확인 | UBS | Buy |
| 2023-04-20 | 재확인 | Wolfe Research | Underperform |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-10-26 | 개시 | Mizuho | Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-06 | 개시 | Wolfe Research | Underperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-27 | 재확인 | Credit Suisse | Outperform |
| 2022-01-27 | 재확인 | Morgan Stanley | Overweight |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | UBS | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-10-27 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-01-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-06-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-06-13 | 재확인 | BofA/Merrill | Buy |
| 2019-02-07 | 재확인 | BofA/Merrill | Buy |
| 2019-01-02 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2018-11-30 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-01-30 | 재확인 | Citigroup | Neutral |
| 2018-01-25 | 재확인 | Stifel | Buy |
| 2018-01-25 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-10-19 | 재확인 | Stifel | Buy |
모두보기
애보트 래버러토리스 주식(ABT)의 최신 뉴스
Bank of New York Mellon Corp Cuts Position in Abbott Laboratories $ABT - MarketBeat
With 80% ownership, Abbott Laboratories (NYSE:ABT) boasts of strong institutional backing - Yahoo Finance
Freestone Capital Holdings LLC Cuts Holdings in Abbott Laboratories $ABT - MarketBeat
How Abbott Laboratories stock trades during market volatility2025 Market Outlook & Smart Money Movement Tracker - newser.com
Q3 Earnings Outperformers: Abbott Laboratories (NYSE:ABT) And The Rest Of The Medical Devices & SuppliesDiversified Stocks - Yahoo! Finance UK
Abbott Laboratories (NYSE:ABT) Is Favoured by Institutional Owners Who Hold 80% of the Company - 富途牛牛
Abbott Laboratories $ABT Shares Bought by State of Michigan Retirement System - MarketBeat
My Favorite Dividend King to Buy in November - The Motley Fool
SS&H Financial Advisors Inc. Grows Stake in Abbott Laboratories $ABT - MarketBeat
Tredje AP fonden Has $109.24 Million Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Stock Holdings Lifted by Tsfg LLC - MarketBeat
iA Global Asset Management Inc. Reduces Position in Abbott Laboratories $ABT - MarketBeat
AlphaStar Capital Management LLC Buys Shares of 2,245 Abbott Laboratories $ABT - MarketBeat
Greater Midwest Financial Group LLC Buys 18,927 Shares of Abbott Laboratories $ABT - MarketBeat
Syverson Strege & Co Acquires 2,723 Shares of Abbott Laboratories $ABT - MarketBeat
Integrity Alliance LLC. Reduces Position in Abbott Laboratories $ABT - MarketBeat
Assetmark Inc. Grows Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Spire Wealth Management - MarketBeat
Abbott Laboratories $ABT Shares Sold by Fisher Funds Management LTD - MarketBeat
Bay Colony Advisory Group Inc d b a Bay Colony Advisors Has $1.22 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
How Abbott Laboratories stock reacts to inflationary pressuresMarket Trend Review & Free Technical Confirmation Trade Alerts - newser.com
Is Abbott Laboratories stock a buy in volatile marketsJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - newser.com
Technical signs of recovery in Abbott LaboratoriesWatch List & Trade Opportunity Analysis - newser.com
Is Abbott Laboratories a candidate for recovery playEarnings Performance Report & Weekly Sector Rotation Insights - newser.com
Looking at the Narrative for Abbott as Legal Wins and Device Growth Shift the Outlook - Yahoo Finance
Simon Quick Advisors LLC Buys 4,430 Shares of Abbott Laboratories $ABT - MarketBeat
Strs Ohio Raises Stake in Abbott Laboratories $ABT - MarketBeat
Amalgamated Bank Purchases 21,362 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Acquired by Atria Investments Inc - MarketBeat
Abbott Laboratories $ABT Shares Sold by Keybank National Association OH - MarketBeat
Hantz Financial Services Inc. Reduces Stock Holdings in Abbott Laboratories $ABT - MarketBeat
World Investment Advisors Boosts Holdings in Abbott Laboratories $ABT - MarketBeat
Will a bounce in Abbott Laboratories offer an exitJuly 2025 Fed Impact & AI Based Buy and Sell Signals - newser.com
Is a relief rally coming for Abbott Laboratories holdersEarnings Risk Report & Free Community Supported Trade Ideas - newser.com
What is the fair value estimate for Abbott Laboratories (ABL) stock in 2025 - newser.com
Daymark Wealth Partners LLC Boosts Stock Holdings in Abbott Laboratories $ABT - MarketBeat
The Zacks Analyst Blog Highlights International Business Machines, Micron and Abbott - sharewise.com
Analyst IMS Investment Management Services Ltd. Decreases Stake in Abbott Laboratories $ABT - MarketBeat
Whalen Wealth Management Inc. Purchases New Position in Abbott Laboratories $ABT - MarketBeat
Jennison Associates LLC Grows Stock Position in Abbott Laboratories $ABT - MarketBeat
Will earnings trigger a reversal in Abbott Laboratories2025 Dividend Review & Risk Managed Investment Strategies - newser.com
Patient sues Abbott after early heart valve replacement - Cardiovascular Business
Top Stock Reports for IBM, Micron & Abbott - Yahoo Finance
Abbott Trifecta Heart Valve Lawsuit Filed Over Device Failure, Removal - AboutLawsuits.com
New York Life Investment Management LLC Acquires 4,494 Shares of Abbott Laboratories $ABT - MarketBeat
Fairfield Financial Advisors LTD Sells 2,587 Shares of Abbott Laboratories $ABT - MarketBeat
Mizuho Markets Americas LLC Sells 8,006 Shares of Abbott Laboratories $ABT - MarketBeat
Biltmore Family Office LLC Has $3.97 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Purchased by Howard Capital Management Inc. - MarketBeat
Barclays Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $162 - 富途牛牛
Transcend Capital Advisors LLC Sells 3,073 Shares of Abbott Laboratories $ABT - MarketBeat
애보트 래버러토리스 (ABT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
0.62%
자본화:
|
볼륨(24시간):